BIOCRYST PHARMACEUTICALS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2012 | — | -128.9% | -148.6% |
| FY2013 | — | -177.2% | -173.7% |
| FY2014 | 100.0% | -336.4% | -332.1% |
| FY2015 | 97.2% | -81.7% | -89.1% |
| FY2016 | 91.3% | -184.4% | -209.3% |
| FY2017 | 95.5% | -227.9% | -261.2% |
| FY2018 | — | -456.2% | -490.3% |
| FY2019 | 92.4% | -203.7% | -223.0% |
| FY2020 | 91.3% | -981.1% | -1,026.4% |
| FY2021 | 95.4% | -113.1% | -117.1% |